Skip to content
Home/Companies/HealthTech/Cure

Cure

HealthTech·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Cure?

Cure is a German HealthTech company, currently owned by J12 Ventures since 2022.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
J12 Ventures
Investor
J12 Ventures
J12 Fund II · 2022 · VC

Key facts

HQGermany
SectorHealthTech
StatusActive

More from J12 Fund II

Other portfolio companies in the same fund.

Pistachio
Active
CybersecurityNorway· 2025
Chapter Two
Active
Data & AnalyticsSweden· 2022
Ostrom
Ostrom
Active
ClimateTechGermany· 2022
Circulate
Active
SaaSSweden· 2021
Jeff
Active
FintechLatvia· 2021
Treyd
Active
FintechSweden· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Cure?

Cure is currently owned by J12 Ventures, through J12 Fund II, since 2022.

When did J12 Ventures acquire Cure?

J12 Ventures acquired Cure in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue